Get started
Author

Max Solenthaler

Observed names: M Solenthaler, M. Solenthaler, SOLENTHALER M, Solenthaler, Max
OpenAlex ID: A5041892684
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 · Miha Furlan, Rodolfo Robles, et al. · New England Journal of Medicine · 1,690
PDF
Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1997 · Miha Furlan, Rodolfo Robles, et al. · Blood · 539
Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura
1998 · Miha Furlan, Rodolfo Robles, et al. · Blood · 327
Programmed death 1 signaling on chronic myeloid leukemia–specific T cells results in T-cell exhaustion and disease progression
2009 · Sabine Mumprecht, Christian Schürch, et al. · Blood · 267
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
2005 · Marianne Bienz, Madleina Ludwig, et al. · Clinical Cancer Research · 235
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
2011 · M C Béné, T Nebe, et al. · Leukemia · 215
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
2007 · Rüdiger Hehlmann, Ute Berger, et al. · Blood · 161
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.
2004 · Johanna A Kremer Hovinga, Jan-Dirk Studt, et al. · PubMed · 66
Randomized trial of dailyversusweekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)
2009 · R. Zenhäusern, S.-F. Hsu Schmitz, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 38
Successful treatment of chemotherapy‐refractory Sézary syndrome with alemtuzumab (Campath‐1H)
2003 · O. Gautschi, N. Blumenthal, et al. · European Journal Of Haematology · 34
PDF
p53 and mdm2 in mantle cell lymphoma in leukemic phase.
2002 · Max Solenthaler, Estella Matutes, et al. · PubMed · 29
Should Whole-Body Red Cell Mass Be Measured or Calculated?
2000 · Ingrid Balga, Max Solenthaler, et al. · Blood Cells Molecules and Diseases · 29
Severe inclusion body β‐thalassaemia with haemolysis in a patient double heterozygous for β°‐thalassaemia and quadruplicated α‐globin gene arrangement of the anti‐4.2 type
1999 · Ph. Beris, M. Solenthaler, et al. · British Journal of Haematology · 22
PDF
Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases
2005 · Valérie Beyer, Dominique Mühlematter, et al. · Cancer Genetics and Cytogenetics · 21
A novel BCR‐ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph‐chromosome and monosomy 7
1999 · Elisabeth Oppliger Leibundgut, Martine Jotterand, et al. · British Journal of Haematology · 21
Using Digital RNA Counting and Flow Cytometry to Compare mRNA with Protein Expression in Acute Leukemias
2012 · Paula Fernandez, Max Solenthaler, et al. · PLoS ONE · 19
PDF
Pyrazinamide‐induced sideroblastic anemia
2011 · Giuseppe Colucci, Tobias Silzle, et al. · American Journal of Hematology · 17
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries
2019 · Sonia Benzarti, Michael Daskalakis, et al. · Cancer Epidemiology · 16
Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia
2009 · Hermann Heimpel, Ulrich Dührsen, et al. · Annals of Hematology · 13
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression
2018 · Alexandra Junge, Ulrike Bacher, et al. · Hematological Oncology · 10
Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis
2003 · Johanna AKremer Hovinga, Max Solenthaler, et al. · European Journal of Gastroenterology & Hepatology · 9
Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02)
2010 · Nicolas Leupin, Jan C. Schuller, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia – a multicentre trial SAKK 32/95
2009 · Reinhard Zenhäusern, Albert Von Rohr, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Leucémies aiguës de l'adulte
2003 · R Zenhäusern, C Zwicky, et al. · Forum Médical Suisse ‒ Swiss Medical Forum · 5
PDF
Venous thrombosis after Caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency
1997 · F. Demarmels Biasiutti, B. Stucki, et al. · European Journal Of Haematology · 5
Works count: 56
Citation count: 3,825
H-index: 17
I10-index: 20
Year
Topic
Type